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Abstract
Retroviruses engage the ESCRT pathway through late assembly (L) domains in Gag to promote virus release. HIV-1 uses a
PTAP motif as its primary L domain, which interacts with the ESCRT-I component Tsg101. In contrast, certain other
retroviruses primarily use PPxY-type L domains, which constitute ligands for NEDD4-type ubiquitin ligases. Surprisingly,
although HIV-1 Gag lacks PPxY motifs, the release of HIV-1 L domain mutants is potently enhanced by ectopic NEDD4-2s, a
native isoform with a naturally truncated C2 domain that appears to account for the residual titer of L domain-defective HIV-
1. The reason for the unique potency of the NEDD4-2s isoform has remained unclear. We now show that the naturally
truncated C2 domain of NEDD4-2s functions as an autonomous Gag-targeting module that can be functionally replaced by
the unrelated Gag-binding protein cyclophilin A (CypA). The residual C2 domain of NEDD4-2s was sufficient to transfer the
ability to stimulate HIV-1 budding to other NEDD4 family members, including the yeast homologue Rsp5, and even to
isolated catalytic HECT domains. The isolated catalytic domain of NEDD4-2s also efficiently promoted HIV-1 budding when
targeted to Gag via CypA. We conclude that the regions typically required for substrate recognition by HECT ubiquitin
ligases are all dispensable to stimulate HIV-1 release, implying that the relevant target for ubiquitination is Gag itself or can
be recognized by divergent isolated HECT domains. However, the mere ability to ubiquitinate Gag was not sufficient to
stimulate HIV-1 budding. Rather, our results indicate that the synthesis of K63-linked ubiquitin chains is critical for ubiquitin
ligase-mediated virus release.
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Introduction
Retroviruses such as HIV-1 usurp the cellular Endosomal
Sorting Complex Required for Transport (ESCRT) machinery to
promote the detachment of infectious progeny virions from the
plasma membrane [1,2,3,4,5]. The ESCRT machinery functions
in membrane invagination and fission, and was originally
identified based on its requirement for the delivery of ubiquitin-
tagged membrane proteins into multivesicular endosomes [6,7].
This process involves the ESCRT-dependent abscission of cellular
vesicles from the limiting membrane of endosomes into their
lumen, which leads to the formation of multivesicular bodies
(MVB) [8,9]. In addition to its role in MVB biogenesis, the
ESCRT machinery is required for midbody abscission during the
terminal stage of cytokinesis [10,11]. Notably, the formation of
endosomal vesicles, the separation of daughter cells, and retroviral
budding are topologically equivalent events. The ESCRT
machinery consists of five heteromeric complexes known as the
ESCRT 0-III and VPS4 complexes, and accessory components
such as ALIX [6,8,12].
Retroviruses recruit the ESCRT machinery through so-called
late assembly (L) domains in Gag, the viral polyprotein that drives
particle assembly and release [13,14]. Subsequent to the formation
of an immature particle, Gag is cleaved by a virally encoded
protease to yield the internal structural components of the mature
virion, including matrix (MA), capsid (CA), and nucleocapsid
(NC). In addition to these Gag components, which are common to
all ortho-retroviruses, HIV-1 Gag possesses a C-terminal p6
domain that harbors two types of L domains. One of these consists
of a conserved PTAP motif that functions as the primary HIV-1 L
domain and binds to ESCRT-I component Tsg101
[15,16,17,18,19,20]. A second L domain in HIV-1 p6 is of the
LYPxnL-type, binds to the V domain of ALIX, and has an
auxiliary role [21,22,23,24,25]. In contrast to HIV-1, the non-
primate lentivirus equine infectious anemia virus engages the
ESCRT pathway exclusively via ALIX [21,22,23]. Ortho-
retroviruses other than lentiviruses primarily use PPxY-type L
domains, which constitute ligands for the WW domains of
NEDD4 family E3 ubiquitin ligases [4,13,14]. Regardless of the
type of L domain used, retroviral budding in general is strongly
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inhibited by dominant-negative versions of ESCRT-III compo-
nents or of VPS4 [18,22,23,24,26,27,28], indicating that the
function of all L domains depends on an intact ESCRT pathway.
However, how PPxY-type L domains ultimately engage the
ESCRT pathway is not yet understood.
The profound release and infectivity defects of HIV-1 PTAP L
domain mutants can be largely corrected by increasing the cellular
expression levels of ALIX [21,29]. This effect of ALIX depends on
the LYPxnL-type L domain in HIV-1 p6 as expected, and also on
the NC domain of Gag, which binds to a different region of ALIX
[30,31,32]. ALIX interacts directly with components of the
ESCRT-III complex [22,23,24,33,34], which is thought to carry
out membrane scission reactions at bud necks [35]. Remarkably,
despite the absence of a PPxY-type L domain from HIV-1 Gag,
the budding, processing, and infectivity defects of HIV-1 L domain
mutants can also be potently corrected through the overexpression
of the NEDD4 family ubiquitin ligase NEDD4-2s [36,37]. In
contrast to ALIX, NEDD4-2s is capable of rescuing HIV-1 release
in the absence of all known L domains [36,37]. To stimulate HIV-
1 budding, NEDD4-2s must be catalytically active, implying that
the conjugation of ubiquitin to a viral or cellular substrate is
required [36,37]. Importantly, an siRNA directed against all
NEDD4-2 isoforms substantially reduced the already low level of
particle production by HIV-1DPTAPP [37], indicating that
NEDD4-2s accounts for a large portion of the residual release
that is often observed in the absence of a Tsg101 binding site.
NEDD4 family ubiquitin ligases have a common modular
architecture, with an N-terminal C2 domain involved in
membrane binding, multiple substrate-binding WW domains,
and a C-terminal HECT domain with intrinsic catalytic activity
[38]. NEDD4-2s is a native, common isoform of human NEDD4-
2 that lacks most of the C2 domain due to alternative exon usage
[39]. However, the portion of the C2 domain that remains is
essential for the ability of NEDD4-2s to stimulate HIV-1 release,
indicating that it constitutes an important functional domain of the
protein [36]. In our hands, NEDD4-2s was unique among several
NEDD4 family members in its ability to rescue HIV-1DPTAPP, with
even full-length NEDD4-2 showing only minimal activity [36]. In
contrast, in a study by Sundquist and colleagues, full-length
NEDD4-2 also stimulated HIV-1DPTAP release and infectivity
[37]. However, in agreement with our results [36], only the
NEDD4-2s isoform reduced the accumulation of Gag processing
intermediates, indicating that NEDD4-2s is uniquely potent [37].
In the present study, we show that the residual C2 domain of
NEDD4-2s constitutes an autonomous HIV-1 Gag-targeting
module that can be functionally replaced by the unrelated HIV-
1 Gag-binding protein cyclophilin A (CypA). Remarkably, CypA
could also substitute for the entire substrate-recognition domain of
NEDD4-2s. When targeted to Gag via the C2 domain remnant of
NEDD4-2s, other NEDD4-type ubiquitin ligases, including yeast
Rsp5, and a subset of isolated HECT domains acquired the ability
to rescue HIV-1 budding. These observations imply that divergent
isolated HECT domains are either capable of recognizing a
functionally relevant substrate when targeted to Gag, or can
engage the ESCRT pathway themselves upon autoubiquitination.
Our results also indicate that the synthesis of K63-linked ubiquitin
chains by NEDD4 family members is critical for the ability to
stimulate virus budding.
Results
Targeting of the catalytic HECT domain of NEDD4-2 to
Gag is sufficient to rescue HIV-1DPTAPP
We previously showed that the residual C2 domain of NEDD4-
2s is required for its ability to rescue HIV-1DPTAPP [36]. Since our
results suggested that the residual C2 domain is needed for
NEDD4-2s to associate with Gag [36], we reasoned that it may be
possible to functionally replace the residual C2 domain with an
unrelated sequence known to bind HIV-1 Gag. To test this
hypothesis, we replaced the residual C2 domain of NEDD4-2s
(residues 1 to 31) with human cyclophilin A (CypA) followed by
HA and FLAG epitopes, yielding Cyp-ND1-31 (Fig. 1). CypA is a
165 amino acid cytosolic protein that binds to the CA domain of
HIV-1 Gag [40,41]. Its presence at the N-terminus of Cyp-ND1-31
was thus expected to target the fusion protein to assembling HIV-1
virions.
Consistent with our previous results [36], we observed a 32-fold
increase in the release of particle-associated CA when 293T cells
were cotransfected with HIV-1DPTAPP and a vector expressing
FLAG-tagged NEDD4-2s (Fig. 1). NEDD4-2s also corrected the
Gag cleavage defect of HIV-1DPTAPP, which leads to the
accumulation of CA-p2 at the expense of mature CA in virus-
producing cells. Although the mechanistic basis for this cleavage
defect remains unknown, impaired processing at the CA-p2 site is
considered a hallmark of late assembly defects. As expected, a
version of NEDD4-2s that had the residual C2 domain precisely
deleted (here called ND1-31) was completely inactive, again
confirming earlier results [36]. In contrast, Cyp-ND1-31 was nearly
as active as WT NEDD4-2s, and stimulated the release of
particulate CA approximately 25-fold. Furthermore, Cyp-ND1-31
partially corrected the Gag processing defect of the Tsg101
binding site mutant (Fig. 1). Thus, the presence of CypA in place
of the residual C2 domain of NEDD4-2s restored activity in the
DPTAPP rescue assay.
The residual C2 domain of NEDD4-2s is separated from the
catalytic HECT domain by an approximately 420-amino-acid
region that harbors four WW domains involved in substrate
binding (Fig. 1). To examine whether this substrate-binding region
is required for the rescue of HIV-1DPTAPP, we fused CypA
followed by HA and FLAG epitopes to truncated versions of
NEDD4-2s that lacked either two (N D1-275) or all four of the WW
domains, in effect leaving only the HECT domain in place
(NHECT). As shown in Fig. 1, both chimeric constructs were highly
Author Summary
To promote its escape from cells, HIV-1 hijacks cellular
budding machinery through so-called L domains in its
structural Gag protein. However, HIV-1 lacks a type of L
domain that recruits NEDD4 ubiquitin ligases, a family of
cellular enzymes that attach one or more copies of a small
protein called ubiquitin to other proteins. Surprisingly, one
NEDD4 family member, which is known as NEDD4-2s and
stands out because its membrane-binding domain is
uniquely truncated, can nevertheless potently stimulate
HIV-1 release. Our study reveals that NEDD4-2s can do this
because its altered membrane-binding domain allows it to
associate with HIV-1 Gag. Remarkably, when tagged with
the altered membrane-binding domain of NEDD4-2s, even
a distantly related yeast protein becomes capable of
stimulating the release of HIV-1. We also show that only
the portion of NEDD4-2s that acts as an enzyme is required
when targeted to HIV-1 Gag in an alternative manner.
Taken together, our findings indicate that it is not simply
the ability to attach ubiquitin to Gag, but rather the ability
to form a particular type of ubiquitin chain in the
immediate vicinity of Gag, that is critical to stimulate virus
release.
NEDD4 Ubiquitin Ligase-Mediated HIV-1 Release
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active in the DPTAPP rescue assay. Specifically, Cyp-ND1-275 and
Cyp-NHECT stimulated the release of particle-associated CA by
30- and 20-fold, respectively. Of note, identical NEDD4-2s
truncation mutants that lack CypA at the N-terminus exhibited
no activity in this assay [36]. We conclude that the targeting of the
isolated catalytic HECT domain of NEDD4-2s to Gag via CypA is
sufficient to rescue HIV-1 budding defects.
Transfer of the residual C2 domain of NEDD4-2s confers
the ability to rescue HIV-1 release to a yeast homologue
In our previous study, the overexpression of the NEDD4 family
ubiquitin ligases NEDD4-1, WWP1, WWP2, or ITCH had no
significant effect on the release of HIV-1DPTAPP [36]. Since all
these proteins possess an intact C2 domain, we had also generated
a variant of WWP1 that lacks the exact portion of the C2 domain
which is naturally absent from NEDD4-2s. The resulting WWP1s
mutant remained inactive in the DPTAPP rescue assay, indicating
that the robust activity of NEDD4-2s is not simply due to its
naturally truncated C2 domain [36]. To determine what region of
NEDD4-2s accounts for its unique ability to rescue HIV-1
budding, we generated FLAG-tagged chimeras between
NEDD4-2s and WWP1 as illustrated in Fig. 2A. Interestingly,
whereas WWP1s exhibited no activity as previously reported [36],
a version that included the first 245 residues of NEDD4-2s (N1-
245/WWP1) was at least as active as WT NEDD4-2s in rescuing
particle production and Gag processing by HIV-1DPTAPP (Fig. 2A).
Quantitation of the amount of virion-associated CA indicated that
NEDD4-2s increased mature particle production 25-fold in this
experiment, whereas N1-245/WWP1 had a 43-fold effect. The N-
terminal 245 residues of NEDD4-2s include the truncated C2
domain, WW domain 1, and the relatively long intervening
segment that separates WW domains 1 and 2. A chimeric
molecule that lacked this intervening segment (N1-110/WWP1)
increased mature particle production by HIV-1DPTAPP almost 20-
fold, despite being poorly expressed (Fig. 2A). Finally, HIV-
1DPTAPP released almost 40-fold more mature CA when co-
expressed with the N1-73/WWP1 chimera (Fig. 2A), demonstrating
that only NEDD4-2s sequences upstream of WW domain 1 were
required for activity.
The results described above suggested to us that the unique
ability of NEDD4-2s to promote HIV-1 budding may be solely
determined by its unique residual C2 domain. To test this notion,
we examined whether we could confer activity to the NEDD4
family member ITCH by replacing its C2 domain with a 37-
amino-acid fragment from NEDD4-2s that harbors its truncated
C2 domain [42]. As shown in Fig. 2B, the resulting N1-37/ITCH
chimera corrected the release and Gag processing defects of HIV-
1DPTAPP as efficiently as NEDD4-2s itself. Although ITCH was
recently reported to potently rescue a murine leukemia virus L
domain mutant [43], we previously observed that native ITCH
does not rescue HIV-1DPTAPP [36]. We thus conclude that the
truncated C2 domain of NEDD4-2s is both required and sufficient
to transfer the ability to rescue HIV-1 budding.
To determine the generality of these findings, we examined
whether it was possible to convert a yeast ubiquitin ligase into a
form capable of correcting HIV-1 budding defects. Saccharomyces
cerevisiae encodes a single essential NEDD4 family ubiquitin ligase,
Rsp5. Like human NEDD4 family members, Rsp5 possesses an N-
terminal C2 domain, WW domains, and a C-terminal HECT
domain. As illustrated in Fig. 2B, we replaced the C2 domain of
FLAG-tagged yeast Rsp5 with the N-terminal 37 amino acids of
human NEDD4-2s, which yielded the N1-37/Rsp5 chimera.
Remarkably, when expressed in human 293T cells together with
HIV-1DPTAPP, the N1-37/Rsp5 fusion protein rescued particle
production and Gag processing by the Tsg101 binding site mutant
as potently as Nedd4-2s, despite being expressed at lower levels
(Fig. 2B). In contrast, the parental FLAG-Rsp5 construct had only
a minor effect on particle production by HIV-1DPTAPP, and did
not noticeably affect the Gag processing defect of HIV-1DPTAPP
(data not shown). We infer that the residual C2 domain of
NEDD4-2s is sufficient to confer the ability to function in HIV-1
budding to widely divergent NEDD4 family members from
different species.
The residual C2 domain of NEDD4-2s confers the ability
to associate with HIV-1 Gag
We previously showed that the residual C2 domain of NEDD4-
2s is required for its ability to induce Gag ubiquitination, and for
Figure 1. The isolated HECT domain of NEDD4-2s rescues HIV-
1DPTAPP when targeted to Gag. 293T cells were transfected with
HXBH10DPTAPP (1 mg) and empty vector, or vectors (2 mg each)
expressing FLAG-tagged WT NEDD4-2s, a version lacking the residual
C2 domain (ND1-31), or versions that have portions of NEDD4-2s
replaced by the HIV-1 Gag-binding protein CypA as illustrated. Virion
pellets and the cell lysates were analyzed by Western blotting to detect
Gag, Gag cleavage products, and FLAG-tagged proteins as indicated.
doi:10.1371/journal.ppat.1001107.g001
NEDD4 Ubiquitin Ligase-Mediated HIV-1 Release
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its incorporation into VLP [36]. To examine these parameters, we
had made use of an HIV-1 Gag construct called ZWT, which has
NC and p6 replaced by a foreign dimerization domain and
efficiently produces VLP in an ESCRT pathway-independent
manner [44,45]. Furthermore, ZWT Gag exhibits less baseline
ubiquitination than authentic HIV-1 Gag. These properties of
ZWT Gag had allowed us to analyze the effect of NEDD4-2s on the
ubiquitination of VLP-associated Gag, and the uptake of NEDD4-
2s into VLP, independent of its effect on VLP production [36].
We used the same ZWT Gag-based assay system as in our
previous study to determine whether chimeric versions of WWP1,
ITCH, or Rsp5 are capable of inducing Gag-ubiquitin conjugates.
All of the parental and chimeric ubiquitin ligase constructs used in
this analysis had N-terminal FLAG tags to allow a comparison of
relative expression levels. As previously reported [36], the co-
expression of ZWT Gag and NEDD4-2s led to the appearance of
additional Gag species in ZWT VLP that migrated slower than the
ZWT Gag precursor (Fig. 3A). We have demonstrated that these
NEDD4-2s-induced bands represent Gag-ubiquitin conjugates
[36]. In contrast, WWP1s, a version of WWP1 that lacks the
portion of the C2 domain that is naturally absent in NEDD4-2s
[36], did not induce Gag-ubiquitin-conjugates in the same assay
(Fig. 3A). Furthermore, in contrast to NEDD4-2s, WWP1s was not
incorporated into ZWT VLP, even though both were expressed at
comparable levels (Fig. 3A). These findings are in agreement with
the lack of activity of WWP1s in the DPTAPP rescue assay [36].
Interestingly, the N1-245/WWP1, N1-110/WWP1, and N1-73/
WWP1 chimeras, which were active in the DPTAPP rescue assay
Figure 2. The residual C2 domain of NEDD4-2s is sufficient to transfer the ability to rescue HIV-1DPTAPP. (A) The transfer of NEDD4-2s
sequences upstream of the first WW domain to WWP1 is sufficient to confer activity in the DPTAPP rescue assay. (B) Human ITCH and yeast Rsp5
potently rescue HXBH10DPTAPP when their C2 domain is replaced by the residual C2 domain of NEDD4-2s. 293T cells were transfected with
HXBH10DPTAPP (1 mg) and vectors (2 mg each) expressing the indicated FLAG-tagged parental or chimeric ubiquitin ligase constructs, or the empty
vector. Virion pellets and the cell lysates were analyzed by Western blotting to detect Gag, Gag cleavage products, and FLAG-tagged proteins as
indicated.
doi:10.1371/journal.ppat.1001107.g002
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(see Fig. 2A), were all incorporated into ZWT VLP and induced a
similar pattern of Gag-ubiquitin conjugates as NEDD4-2s
(Fig. 3A).
Similar results as with the WWP1-based chimeras were
obtained with N1-37/ITCH and N1-37/Rsp5 (Fig. 3B). We found
that N1-37/ITCH and N1-37/Rsp5 both induced a very similar
extent of Gag ubiquitination as NEDD4-2s. Further, particularly
in the case of N1-37/Rsp5, the pattern of Gag-ubiquitin conjugates
was virtually indistinguishable from that induced by NEDD4-2s.
Also, both N1-37/ITCH and N1-37/Rsp5 were taken up into VLP
even more efficiently than NEDD4-2s. Together, these results
imply that the residual C2 domain of NEDD4-2s is sufficient to
transfer the ability to associate with HIV-1 Gag to other NEDD4
family members, which thereby gain access into VLP and the
ability to ubiquitinate Gag.
Isolated HECT domains differ in their ability to rescue
HIV-1 budding if fused to the residual C2 domain of
NEDD4-2s
As described above, we found that the isolated HECT domain
of NEDD4-2s is sufficient to rescue HIV-1DPTAPP if brought into
contact with Gag. Furthermore, our results suggested that the
Figure 3. The residual C2 domain of NEDD4-2s functions as a Gag-targeting module. (A) NEDD4-2s sequences upstream of the first WW
domain are sufficient to induce the ubiquitination of an L domain-independent HIV-1 Gag construct (ZWT) by WWP1, and the association of WWP1
with ZWT VLP. (B) Human ITCH and yeast Rsp5 ubiquitinate ZWT Gag and associate with ZWT VLP when their C2 domain is replaced by the NEDD4-2s
residual C2 domain. 293T cells were transfected with the ZWT Gag construct (2 mg) and vectors (2 mg each) expressing the indicated FLAG-tagged
parental or chimeric ubiquitin ligase constructs, or the empty vector. VLP were analyzed by Western blotting with anti-CA to detect unmodified and
ubiquitinated versions of ZWT Gag, and with anti-FLAG to detect the incorporation of ubiquitin ligase constructs into VLP. The cell lysates were also
examined with anti-FLAG.
doi:10.1371/journal.ppat.1001107.g003
NEDD4 Ubiquitin Ligase-Mediated HIV-1 Release
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residual C2 domain of NEDD4-2s can serve as a Gag-binding
module. We therefore asked whether the isolated HECT domains
of other human HECT ubiquitin ligases can promote HIV-1
budding if fused to the residual C2 domain of NEDD4-2s. Among
the HECT domains included in this analysis were those of the
NEDD4 family members SMURF1, HECW1, and HECW2,
which are derived from different ancestral genes than NEDD4-2s,
WWP1, or ITCH [46]. Additionally, we included the HECT
domains of E6AP and of HERC6, which belong to the SI-HECT
and HERC subfamilies of HECT E3s, respectively [38]. All
HECT domains were directly appended to a FLAG-tagged
version of the residual C2 domain of NEDD4-2s, and the fusion
proteins were expressed in 293T cells together with HIV-1DPTAPP.
Two of the HECT domain constructs (N1-37/HECW1HECT and
N1-37/HECW2HECT) rescued both particle production and the
conversion of CA-p2 to mature CA to a similar extent as full-
length NEDD4-2s, which served as a positive control (Fig. 4). In
the experiment shown in Fig. 4, NEDD4-2s stimulated particle
production 28-fold, and the HECT domain constructs N1-37/
HECW1HECT and N1-37/HECW2HECT enhanced virus release
24- and 20-fold, respectively. On the other hand, equivalent
constructs that harbored the HECT domains of SMURF1, E6AP,
or HERC6 were poorly active or inactive in the DPTAPP rescue
assay, even though all were well expressed (Fig. 4).
As shown in Fig. 5A, the two HECT domain constructs that
were active in the DPTAPP rescue assay (N1-37/HECW1HECT and
N1-37/HECW2HECT) induced the ubiquitination of ZWT Gag to a
comparable extent as NEDD4-2s. In contrast, the constructs
harboring the HECT domains of SMURF1, E6AP, or HERC6
failed to induce Gag ubiquitination. It is possible that the isolated
HECT domains of E6AP and HERC6 lacked catalytic activity,
since no evidence for autoubiquitination was apparent. Also,
HERC6 is an interferon-induced protein that, based on similarity
to human HERC5 and mouse HERC6, may be a ligase for ISG15
rather than ubiquitin [47,48].However, the N1-37/SMURF1HECT
construct appeared as capable of autoubiquitination as the two
HECT domain constructs that efficiently rescued HIV-1 budding
(Fig. 5A; also see Fig. 4).
To more directly determine whether the HECT domain
constructs were capable of associating with HIV-1 Gag, we also
examined their incorporation into ZWT VLP. The two active
HECT domain constructs were readily detectable in VLP. If fact,
relative to their expression levels, N1-37/HECW1HECT and N1-37/
HECW2HECT were incorporated at 14- and 46-fold higher levels
than NEDD4-2s, respectively. In contrast, two of the three inactive
constructs (N1-37/SMURF1HECT and N1-37/E6APHECT) were not
incorporated, even though they were expressed as well or better
than the constructs that were taken up into VLP. The third
inactive construct (N1-37/HERC6HECT) was incorporated at about
4-fold higher levels than NEDD4-2s, normalized for expression
levels (Fig. 5A). The N1-37/HECW2HECT construct exhibited the
lowest level of expression but the highest level of VLP association,
which suggested that the HECT domain of HECW2 in particular
contributed to the association with HIV-1 Gag. However, a
version of N1-37/HECW2HECT that lacked the residual C2
domain of NEDD4-2s did not induce Gag ubiquitination, was
not incorporated into VLP, and was inactive in the DPTAPP
rescue assay (Fig. 5B and data not shown).
Taken together, these results show that the residual C2 domain
of NEDD4-2s is sufficient to target a subset of isolated HECT
domains to HIV-1 Gag. They also show that the isolated HECT
domain of NEDD4-2s is not unique in its ability to rescue HIV-1
budding when targeted to Gag. Rather, this ability is shared by the
HECT domains of the two human NEDD4 family members that
are overall most divergent from NEDD4-2s.
Induction of Gag ubiquitination is not sufficient to rescue
of HIV-1 budding
The apparent inability of the N1-37/SMURF1HECT construct to
associate with HIV-1 Gag offered a possible explanation for its
failure to rescue HIV-1DPTAPP and to ubiquitinate ZWT Gag,
despite being able to auto-ubiquitinate. We therefore examined
the effect of targeting the SMURF1 HECT domain to HIV-1 Gag
via CypA. As shown in Fig. 6A, fusing the HECT domains of
SMURF1, E6AP, or HERC6 directly to CypA did not confer the
ability to rescue HIV-1DPTAPP. In contrast, the equivalent Cyp-
NHECT construct, which instead contains the HECT domain of
NEDD4-2s, did rescue nearly as well as WT NEDD4-2s, as
expected. Although all CypA-HECT domain fusion proteins were
incorporated into ZWT VLP, those containing the HECT domain
of E6AP or HERC6 did not ubiquitinate ZWT Gag, consistent
with the possibility that these HECT domains are catalytically
inactive in isolation (Fig. 6B). Surprisingly, the CypA fusion
proteins with the NEDD4-2s and SMURF1 HECT domains
induced comparable levels of Gag-ubiquitin conjugates (Fig. 6B),
Figure 4. Rescue of HIV-1DPTAPP by isolated HECT domains
fused to the NEDD4-2s residual C2 domain. 293T cells were
transfected with HXBH10DPTAPP (0.5 mg) and empty vector, or vectors
expressing FLAG-tagged versions of NEDD4-2s (2 mg) or of the
indicated fusion proteins (6 mg each). Virion pellets and the cell lysates
were analyzed by Western blotting to detect Gag products and FLAG-
tagged proteins as indicated.
doi:10.1371/journal.ppat.1001107.g004
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even though only the former was active in the DPTAPP rescue
assay (Fig. 6A). Moreover, although the CypA fusion protein with
the NEDD4-2s HECT domain (Cyp-NHECT) and WT NEDD4-2s
exhibited comparable activities in the DPTAPP rescue assay
(Fig. 6A), the former induced a much lower level of ZWT Gag
ubiquitination (Fig. 6B). These results demonstrate that the mere
ability to ubiquitinate Gag is not sufficient to rescue HIV-1
budding. Furthermore, if the ubiquitination of Gag is necessary to
promote budding, then only relatively low levels of Gag
ubiquitination are required.
Figure 5. The NEDD4-2s residual C2 domain is sufficient to target some isolated HECT domains to Gag. (A) Residual C2 domain/HECT
domain fusion proteins differ in their ability to induce the ubiquitination of ZWT Gag, and to associate with ZWT VLP. (B) The ubiquitination of ZWT Gag
by the isolated HECT domain of HECW2 and its association with ZWT VLP were dependent on the presence of the NEDD4-2s residual C2 domain. 293T
cells were transfected with the ZWT Gag construct (2 mg) and empty vector, or vectors expressing FLAG-tagged versions of NEDD4-2s (2 mg) or of the
indicated HECT domain constructs (6 mg each).
doi:10.1371/journal.ppat.1001107.g005
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Rescue of HIV-1 budding correlates with chain type
specificity
The lack of correlation between the rescue of HIV-1 budding
and the overall levels of Gag ubiquitination led us to investigate
the possible role of the type of ubiquitin chain that can be formed.
It was recently shown that ITCH, which potently rescues HIV-1
budding when targeted to Gag (Fig. 2B), has a very high
preference for the synthesis of K63-linked polyubiquitin chains
[49]. However, the replacement of the C lobe of the HECT
domain of ITCH by that of E6AP caused a complete switch to
K48 chain type specificity [49]. On the other hand, an ITCH-
HUWE1 C-lobe chimera produced both relatively short K48
chains and even shorter K63 chains [49]. HUWE1 is a large
HECT domain ubiquitin ligase that does not belong to the
NEDD4 family, but is relatively closely related in its HECT
domain.
To examine the role of chain type specificity in the rescue of
HIV-1 budding, we replaced the C lobe of N1-245/ITCH by that
of E6AP or HUWE1, as illustrated in Fig. 7A. N1-245/ITCH
rescues HIV-1DPTAPP as potently as N1-37/ITCH, and was used
here because HECT C lobe chimeras based on this construct were
relatively stable (data not shown). The N1-245/ITCH E6AP C lobe
chimera appeared to have no effect on HIV-1 budding, but was
too poorly expressed to yield reliable results (data not shown). In
contrast, the N1-245/ITCH-HUWE1 C lobe chimera was
expressed at higher levels. However, even at expression levels
similar to or higher than those obtained with the parental N1-245/
ITCH construct, N1-245/ITCH-HUWE1 had at most a small
effect on the release of HIV-1DPTAPP, whereas N1-245/ITCH potent-
ly rescued budding (Fig. 7B). Nevertheless, the parental N1-245/
ITCH construct and N1-245/ITCH-HUWE1 induced compara-
ble levels of ubiquitination both of ZWT Gag (Fig. 7C) and of
authentic HIV-1 Gag expressed by a proviral protease mutant
(Fig. 7D).
Interestingly, the pattern of ZWT Gag ubiquitination seen with
N1-245/ITCH-HUWE1 differed slightly from that obtained with
N1-245/ITCH (Fig. 7C), consistent with the possibility that these
two proteins catalyze different chain linkages, as previously shown
for ITCH-HUWE1 and ITCH in vitro [49]. To examine this possi-
bility directly, we made use of the linkage-specific antibodies Apu3
and HWA4C4, which exhibit high selectivity for K63-linked ubi-
quitin chains [50,51]. In the experiment shown in Fig. 7E, N1-245/
ITCH-HUWE1 was more highly expressed than N1-245/ITCH,
and induced higher overall levels of ZWT Gag ubiquitination as
detected by immunoblotting of ZWT particles with anti-CA
antibody (left panel). Nevertheless, when the same samples were
examined by Western blotting with the K63-linkage specific Apu3
antibody, only the parental N1-245/ITCH construct yielded three
prominent bands (right panel). The mobility of these three bands
was as expected for ZWT Gag modified with di-, tri-, or tetra-
ubiquitin chains. Equivalent results were obtained with HWA4C4,
another K63-linkage specific antibody (data not show). We con-
Figure 6. Induction of Gag ubiquitination is not sufficient to rescue of HIV-1 release. (A) The isolated HECT domain of NEDD4-2s rescues
HXBH10DPTAPP when targeted to Gag via CypA (lane 2), whereas the isolated HECT domains of SMURF1, E6AP, or HERC6 do not (lanes 3–5). (B) The
isolated HECT domains of NEDD4-2s (lane 2) and SMURF1 (lane 3) induced comparable levels of Gag ubiquitination when fused to CypA. 293T cells
were transfected with HXBH10DPTAPP (0.5 mg) or ZWT (2 mg) and empty vector, or vectors expressing the indicated FLAG/HA-tagged CypA-HECT
domain fusion proteins or FLAG-tagged NEDD4-2s (2 mg each). Gag proteins were detected with anti-CA, and the CypA-HECT fusion proteins were
detected with anti-FLAG or anti-HA, as indicated.
doi:10.1371/journal.ppat.1001107.g006
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clude that the chain type specificities of N1-245/ITCH and N1-245/
ITCH-HUWE1 in living cells differ considerably, and that the
ability to catalyze K63-linked chains is of critical importance for the
rescue of HIV-1 release.
Discussion
We show here that widely divergent human and yeast ubiquitin
ligases of the NEDD4 family, and even a subset of isolated HECT
domains, possess the intrinsic ability to function in HIV-1 release.
The truncated C2 domain of NEDD4-2s provides a natural Gag-
targeting module, which accounts for the unique ability of
authentic NEDD4-2s to rescue HIV-1 budding defects. However,
other NEDD4 family members, including yeast Rsp5, and in some
cases even their isolated catalytic HECT domains, acquire the
same ability if targeted to HIV-1 Gag. A common property that is
shared by widely divergent NEDD4 family members is the
preferential catalysis of K63-linked ubiquitin chains, and at least in
the case of yeast Rsp5, the isolated HECT domain is sufficient to
synthesize such chains [49]. Our data support a model in which
the ability to conjugate K63 chains to a viral or cellular substrate
in the immediate vicinity of the emerging bud is central to the
ability to stimulate virus release.
In our previous study, the unique potency of NEDD4-2s in the
DPTAPP rescue assay did depend on its C2 domain being
truncated, and was not shared by several other NEDD4 family
members with intact C2 domains [36]. One possible explanation
for these observations was that the natural truncation of the C2
domain in NEDD4-2s relieves an autoinhibition, which would be
consistent with a study showing that the catalytic activity of a
subset of C2-WW-HECT E3s is regulated through an inhibitory
interaction between their C2 and HECT domains [42]. On the
other hand, the residual C2 domain of NEDD4-2s was essential
for activity in the DPTAPP rescue assay [36]. This finding raised
the possibility that the C2 domain remnant of NEDD4-2s, which
corresponds to b-strands 7 and 8 of the intact domain [42],
constitutes a functional domain on its own that plays an active role
in the rescue of HIV-1 budding. The present study supports this
notion by demonstrating that the residual C2 domain of NEDD4-
2s is sufficient to transfer the ability to rescue HIV-1 budding
defects to other NEDD4 family ubiquitin ligases, and even to a
subset of isolated HECT domains.
Our previous results suggested that the C2 domain remnant of
NEDD4-2s is required for activity in the DPTAPP rescue assay,
because it mediates the association of the ubiquitin ligase with
HIV-1 Gag [36]. In support of this concept, we now show that
other NEDD4 family members, and some isolated HECT
domains, associate with HIV-1 Gag if tagged with the residual
C2 domain of NEDD4-2s. Additional strong support is provided
by the fact that we were able to functionally replace the C2
domain remnant of NEDD4-2s with CypA, an entirely unrelated
protein that has long been known to specifically interact with HIV-
1 Gag [40,41].
HECT E3s contain two broad functional regions: a large N-
terminal region required for substrate recognition, and a C-
terminal region (the HECT domain) which catalyzes the
ubiquitination of bound substrates [52]. Apart from the C2
domain, the N-terminal regions of NEDD4 family members
harbor multiple WW domains, which we previously found
dispensable for the rescue of HIV-1 budding by NEDD4-2s
[36]. In the present study, essentially the entire N-terminal
substrate recognition portion of NEDD4-2s became dispensable in
the presence of CypA, which served as a Gag-targeting module.
The simplest interpretation of this result is that no substrate other
than Gag needs to be recognized to stimulate virus release.
However, if a transacting factor rather than Gag is the relevant
substrate for ubiquitination as proposed [53], then the isolated
catalytic HECT domain of NEDD4-2s must be sufficient to
recognize that factor.
One potential transacting factor is ESCRT-I, because Sund-
quist and colleagues have demonstrated that the stimulation of
HIV-1DPTAPP release by NEDD4-2s depends on Tsg101/ESCRT-
I [37]. Furthermore, these authors showed that NEDD4-2s
overexpression induces the ubiquitination of ESCRT-I complexes,
particularly of those that contain MVB12B. They also reported
that a PPQY sequence in MVB12B, which constitutes a potential
binding site for WW domains, contributes to the ubiquitination of
MVB12B/ESCRT-I complexes by NEDD4-2s. Based on these
results, it was suggested that NEDD4-2s-mediated ubiquitination
may activate ESCRT-I to function in HIV-1 release [37]. If this
hypothesis is correct, then our observations imply that NEDD4-2s
must remain capable of recognizing ESCRT-I as a substrate even
in the absence of its N-terminal substrate recognition domain.
It has also been suggested that NEDD4 family E3s interact
through their HECT domains with as yet unknown components of
the ESCRT pathway, because several NEDD4 family members,
and the isolated HECT domain of WWP1, localized to aberrant
endosomal class E compartments induced by dominant-negative
VPS4 [54]. We have now observed that Rsp5, the single C2-WW-
HECT E3 of Saccharomyces cerevisiae, can strongly stimulate HIV-
1DPTAPP release and Gag processing when its C2 domain is
replaced. Thus, if an interaction with an ESCRT pathway
component is required for activity in the DPTAPP rescue assay,
such an interaction and the interfaces involved must be conserved
between yeast and man. One reported interaction that potentially
meets these criteria is that between NEDD4 and ALIX or their
yeast homologues Rsp5 and Bro1 [55]. Notably, the protein
regions involved in the interaction appear conserved, because
yeast Rsp5 co-immunoprecipitated with mammalian ALIX [55].
However, the NEDD4-ALIX interaction may depend on WW
domains [55], which are dispensable for the ability of NEDD4-2s
to rescue HIV-1DPTAPP [36].
In principle, ESCRT pathway components could also be
recruited via ubiquitinated Gag, because the upstream ESCRT
complexes each possess at least one component that binds
ubiquitin [6,56]. For instance, the human ESCRT-I components
Figure 7. Rescue of HIV-1 release correlates with chain type specificity. (A) Schematic illustration of chimeric ubiquitin ligase constructs. The
C lobe of HUWE1 is indicated in yellow. (B to D) Replacement of the C lobe of the ITCH HECT domain by that of HUWE1 greatly impairs the rescue of
HIV-1DPTAPP by a NEDD4-2s/ITCH chimera (panel B), but not the overall ubiquitination of VLP-associated ZWT Gag (panel C) or of virus particle-
associated authentic Gag expressed by an HIV-1 provirus lacking protease (panel D). Expression vectors for HECT domain constructs were transfected
in varying amounts as indicated to achieve comparable expression levels. (E) The parental N1-245/ITCH construct, in contrast to the N1-245/ITCH-
HUWE1 HECT domain chimera, induces the attachment of K63-linked chains to ZWT Gag. 293T cells were transfected with the ZWT Gag construct and
empty vector, or vectors expressing FLAG-tagged versions of the indicated HECT domain constructs. VLP samples were analyzed by Western blotting
with anti-CA to detect unmodified and ubiquitinated versions of ZWT Gag (left panel), and in parallel with Apu3 to detect K63-linked ubiquitin chains
conjugated to ZWT Gag (right panel). The cell lysates were also examined with anti-FLAG.
doi:10.1371/journal.ppat.1001107.g007
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Tsg101 and VPS37A contain ubiquitin-binding domains [12]. It
was also recently reported that the ESCRT-associated protein
ALIX specifically binds to ubiquitin [57].However, at least the
ubiquitin-binding activity of Tsg101 is not required for the rescue
of HIV-1 budding by NEDD4-2s [37]. Also, there is evidence that
the ubiquitination of Gag is dispensable, because the PPxY-
dependent budding of a foamy virus Gag protein completely
devoid of ubiquitin acceptors could be stimulated by catalytically
active WWP1 [53]. However, in the latter case, Gag-associated
WWP1 could have served as an alternative ubiquitin acceptor,
since the enzyme is capable of auto-ubiquitination.
K63-linked ubiquitin chains are required for the transport of at
least some cargo into MVB [56], and have also been implicated in
the function of PPxY-type L domains [58], which act by recruiting
NEDD4 family members [13]. Several NEDD4 family members
have indeed been shown to preferentially synthesize K63-linked
ubiquitin chains, including mammalian NEDD4-1 and ITCH
[49,59,60], as well as yeast Rsp5 [49,61]. In contrast, E6AP,
another HECT domain E3, preferentially synthesizes K48-linked
chains, which provide a signal for proteasomal degradation [59]. At
least in the case of ITCH, chain type specificity is determined by the
C lobe of the HECT domain [49]. For instance, the replacement of
the C lobe of ITCH with that of HUWE1 considerably reduces the
preference for the synthesis of K63 chains [49]. In the present study,
we observed that an ITCH/HUWE1 C lobe chimera did not
efficiently rescue HIV-1 budding. Interestingly, the C lobe chimera
retained the ability to efficiently ubiquitinate Gag, but lacked the
ability of the parental ITCH construct to induce the attachment of
K63-linked ubiquitin chains to Gag. Taken together, these data
indicate that the ability to synthesize K63 chains is crucial for the
stimulation of HIV-1 budding.
Structural studies indicate that the conformations of K63- and
K48-linked chains are markedly distinct. Specifically, K63-linked
di- or tetraubiquitin chains exhibit an extended conformation in
which functionally important surface hydrophobic residues are
constitutively exposed, whereas K48-linked chains can adopt a
closed conformation in which these hydrophobic surface residues
are sequestered [62,63,64]. It is thus likely that linkage-specific
conformations provide a basis for the recruitment of distinct
cellular recognition factors. Interestingly, it has recently emerged
that K63-linked ubiquitin chains serve as specific signals for the
ESCRT-dependent sorting of cargo into MVBs [56]. For instance,
in the case of the yeast membrane protein Gap1, monoubiquitina-
tion is sufficient for its efficient endocytosis [65]. However, the
presence of short K63-linked chains is required for the entry of
Gap1 into the MVB pathway [65], suggesting preferential
recognition of K63-linked chains by some component of the
ESCRT machinery. The results presented here imply that HECT
ubiquitin ligase-stimulated virus budding, which is also ESCRT-
dependent [13,66], is governed by the same type of ubiquitin
modification.
Materials and Methods
Proviral constructs
HXBH10DPTAPP is a mutant of HXBH10, a vpu-positive version
of the infectious HXB2 proviral clone of HIV-1, with an in-frame
deletion of codons 7 through 11 of p6 [44]. The ZWT variant of
HXBH10 encodes a chimeric Gag precursor that has NCp1p6
replaced by a leucine zipper dimerization domain [44].
Expression vectors
Plasmids expressing NEDD4-2s, ND1-31 (residues 32–834 of
NEDD4-2s), or WWP1s (residues 110–922 of WWP1) with an N-
terminal FLAG tag have been previously described, and are based
on the mammalian expression vector pBJ5 [36]. Vectors
expressing CypA-HA/FLAG-NEDD4-2s fusion proteins were
created using an overlap extension technique [67]. First, DNA
fragments with overlapping ends were amplified in separate PCR
reactions, using previously described vectors encoding CypA-HA
and FLAG-tagged NEDD4-2s truncation mutants as templates
[36,68]. The two fragments were then recombined in a second
PCR reaction as described [67], and inserted into pBJ5. The
resulting Cyp-ND1-31, Cyp-ND1-275, and Cyp-NDHECT constructs
encode CypA followed by HA and FLAG epitopes, which in turn
are followed by NEDD4-2s residues 32–834, 276–834, and 432–
834, respectively. Vectors expressing CypA-HA/FLAG fused to
the isolated HECT domains of SMURF1 (residues 366–757),
E6AP (residues 462–852), or HERC6 (residues 637–1014) were
made in an analogous manner using Cyp-ND1-31 and cDNA clones
encoding SMURF1 (KIAA1625), E6AP (BC009271), or HERC6
(BC042047) as templates. Overlap extension PCR was also used to
generate pBJ5-based vectors expressing FLAG-tagged residues 1–
73, 1–110, or 1–245 of NEDD4-2s fused to residues 383–922 of
WWP1 (yielding N1-73/WWP1, N1-110/WWP1, and N1-245/
WWP1), using previously described vectors expressing FLAG-
NEDD4-2s and FLAG-WWP1s as templates [36]. Furthermore,
overlap extension PCR was used to generate pBJ5-based vectors
expressing FLAG-tagged residues 1–37 of NEDD4-2s fused to
residues 142–862 of ITCH (yielding N1-37/ITCH), residues 138–
809 of yeast Rsp5 (yielding N1-37/Rsp5), residues 366–757 of
SMURF1 (yielding N1-37/SMURF1HECT), residues 1207–1606 of
HECW1 (yielding N1-37/HECW1HECT), residues 1162–1572 of
HECW2 (yielding N1-37/HECW2HECT), residues 462–852 of
E6AP (yielding N1-37/E6APHECT), or residues 637–1014 of
HERC6 (yielding N1-37/HERC6HECT). The templates used
included previously published plasmids [36,49,69] and cDNA
clones KIAA1625 (SMURF1), KIAA0322 (HECW1), KIAA1301
(HECW2), BC009271 (E6AP), and BC042047 (HERC6). The
cDNA clones were provided by the Kazusa DNA Research
Institute or purchased from Open Biosystems. Of note, each
HECT domain construct includes the N-terminal H19 helix of the
HECT domain [70]. An expression vector for full-length Rsp5
with an N-terminal FLAG tag was generated using standard PCR.
Finally, overlap extension PCR was used to generate pBJ5-based
vectors expressing FLAG-tagged residues 1-245 of NEDD4-2s
fused to residues 142-862 of WT ITCH (NM_031483), or to
versions of ITCH in which the C lobe of the HECT domain has
been replaced with the corresponding region of E6AP or HUWE1
[49].
Assays for viral particle production and Gag
ubiquitination
293T cells (1.26106) were seeded into T-25 tissue culture flasks
24 hrs prior to transfection. A calcium phosphate precipitation
technique was used to transfect cells with HXBH10DPTAPP
(between 0.5 and 1 mg) or ZWT proviral DNA (2 mg), along with
expression vectors encoding the indicated E3 constructs (between
1 and 6 mg) or empty vector. Total DNA transfected was
normalized to 8 mg by the addition of carrier DNA (pTZ18U).
At 24 hrs post-transfection, cell culture supernatants were
removed and clarified by low-speed centrifugation and passage
through a 0.45 mm filter. Clarified supernatants were layered on to
20% sucrose, and viral particles were separated using high-speed
centrifugation (27,000 rpm, 2 h, 4uC). Cells were lysed using 1 x
RIPA buffer with protease inhibitors. Virus pellets and cell lysates
were analyzed by SDS-PAGE and Western blotting. The anti-
HIV CA antibody 183-H12-5C was used to detect Gag, Gag
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cleavage products, and Gag-ubiquitin conjugates. Ectopically
expressed ubiquitin ligase constructs were detected using anti-
FLAG (M2; Sigma) or anti-HA antibodies (HA.11; Covance). The
K63-linkage specific antibodies Apu3 and HWA4C4 were
purchased from Millipore. Western blots were quantitated with
the ImageJ software.
Accession numbers
NEDD4-2s: BC000621; WWP1: BC036065; ITCH: NM_
031483; SMURF1: NM_020429; HECW1: NM_015022; HECW2:
NM_020760; E6AP: NM_130838; HERC6: BC042047; HUWE1:
NM_031407; CypA: NM_021130.
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